To investigate a new study drug to see if it may help adults living with moderate to severe atopic dermatitis.
Study Details
Study Id: CA43-219538
Age: 18-75
Delivery Method: Injection
Study Length: 32 Weeks
Compensation: May be available for qualified participants.
Atopic dermatitis, the most common type of eczema, is a chronic disease that causes skin inflammation, redness, and irritation. This skin condition is a result of an overactive immune system that causes the skin barrier to become dry and itchy.
The purpose of this study is to learn more about the study drug, GSK1070806. Researchers want to find the best dose (amount) of study drug that can safely help adults with moderate to severe atopic dermatitis.
Your commitment to this study will be a key element in helping researchers find potential treatment options for atopic dermatitis.
Eligible participants will:
- Be 18-75 years of age
- Have had moderate to severe atopic dermatitis for 1 year or longer
- Have taken one prior biologic (injectable) treatment but stopped treatment due to either: Non-response, partial response, loss of response, or side effects or
- Are currently receiving your first biologic (injectable) treatment and experiencing: Non-response, partial response, loss of response, or side effects.
What happens during the study?
Informed Consent
First, the study doctor and team will make sure you understand the study. They will give you an informed consent form that explains the study. They will review each part of the study with you and answer any questions you may have.
Screening Period (4 weeks; 1 visit)
If you sign the informed consent form, the study doctor and team will review your medical history. They will also run some tests and ask questions to learn more about your atopic dermatitis. Based on the results, they will determine if the study is right for you.
Study Treatment Period (16 weeks; 12 visits)
If the study is right for you, you will come to the study site for study treatment, tests, and health checks. You will receive two study treatment injections.
Follow-up Period (12 weeks; 3 visits)
After you complete the study treatment, you will have 3 more visits with the study doctor and team. They will continue to check your health and your atopic dermatitis.
Fill out this form or call our clinical trial line 289-763-8666 to discuss if this trial is right for you.
- 105-5 Quarry Ridge Rd. Barrie, On, L4M 7G1